Chemistry with a treatment question
Angela Russell works across chemistry, biology and medicine at Oxford. She investigates molecules and biological processes that could contribute to treatments, particularly through regeneration and repair. Her work includes both fundamental questions and the difficult task of moving potential therapies towards clinical testing.
When early promise did not last
Russell describes a potential treatment for Duchenne muscular dystrophy that did not show lasting benefit in its clinical trial, despite encouraging interim findings. Investigating why it failed became a major lesson. Later compounds she describes were still being studied in early models, not established treatments for patients.
An unexpected benefit of changing course
Russell began university in biochemistry, then switched to chemistry after deciding she needed different skills for the work she hoped to do. She later found that familiarity with both subjects helped her interdisciplinary research. That advantage was not a strategy she had planned from the start.
A direction, and practical next steps
For interested students, she suggests thinking about a broad longer-term goal, then seeking advice about the steps towards it. Her reflections on research also leave room for failure: an idea needs scientific reasons to pursue it, and evidence can show when a direction is wrong.